期刊文献+

在新生儿呼吸机相关性肺炎抗生素治疗中的应用 被引量:5

Value of detection of serum procalcitonin in guidance of antibiotic therapy of neonatal ventilator associated pneumonia
原文传递
导出
摘要 目的探讨血清降钙素原(PCT)检测在新生儿呼吸机相关性肺炎(VAP)治疗中对抗菌药物使用的指导意义。方法选取56例新生儿呼吸机相关性肺炎患儿随机分成两组:PCT组30例,对照组26例,PCT组根据血清PCT检测水平来判断抗生素的使用;常规组根据患者血CRP、X线胸片、痰培养以及其他实验室检查判断抗生素的使用。观察两组新生儿的抗生素使用时间、使用率、住院时间、死亡率等。结果 PCT组的抗生素使用时间为(9.5±1.9)d,对照组为(11.8±2.1)d,两组差异有统计学意义(t=4.3,P=0.0001);两组的抗生素使用率、住院时间、死亡率及再发率差异无统计学意义(P>0.05)。结论 PCT可有效指导新生儿呼吸机相关性肺炎的抗生素治疗,明显缩短抗生素使用时间,减少抗生素暴露。 Objective To assess the value of detection ofserum procalcitonin(PCT) in guidance of use of antibiotics forthe treatment of neonatal ventilator associated pneumonia(VAP). Methods The 56 neonatal ventilator associated pneumoniacases were randomly divided into PCT group(n=30) and the control group(n=26), The use of antibiotics in cases in PCT groupwas determined according to the serum PCT levels, while the use of antibiotics in cases of control group was determinedaccording to the parameters of patients’ blood CRP, X-ray chest radiograph, sputum culture and other laboratory examinationThe time of antibiotics use, rate, duration of hospitalization and death rate,etc. in the two groups were analyzed. Results Thetime of antibiotics use was shorter in the control group than in of the PCT group, showing significant difference[(9.5±1.9) d vs(11.8±2.1)d, t =4.3, P =0.0001]. There was no statistically significant difference in antibiotics usage, duration of hospitalizationand death rate between the PCT group and the control group(P 〉0.05). Conclusion The PCT can be used for effectiveguidance of treatment of neonatal ventilator associated pneumonia with antibiotics and leading to shortening time of antibioticsuse and reducing exposure time.
出处 《中国热带医学》 CAS 2015年第3期341-343,358,共4页 China Tropical Medicine
基金 深圳市宝安区科技计划项目(No.2013175)
关键词 降钙素原 新生儿 呼吸机相关性肺炎 抗菌药物 Procalcitonin Neonatal Ventilator-associated pneumonia antimicrobial drug
  • 相关文献

参考文献16

  • 1Fischer JE, Ramser M, Fanconi S. Use of antibiotics intens-ive care and potential savings [J]. Intensive Care Med,2000,26(6) : 959-966.
  • 2Brunlhorst F M,AI-Nawas B,Krunmmenauer F,et al.Procalcitonin,C re- active protein and APACHE II score for risk evaluation in patients with severe pneumonia [J].Clin Microbial Infect,2002,8(2):93-100.
  • 3Bouadma L,Luyt CE,Tubach F,et al.Use of procalcitonin to reduce pa- tients' exposure to antibioties in intensive care units(PRORATA trial): a multicentre randomised controlled trial [J].Lancet,2010,375:4fi3- 474.
  • 4Medun GU.Diagnosis of ventilator-associated pneumonia [J].Infect Dis Clin North Am, 2003,7(2):295-329.
  • 5Schuetz P, Batschw Aroff M, Dusemund F, et al. Effetiveness of a pro- ealeitonin algorithm to guide antibiotic therapy in respiratory tract in- fections outside of study conditions: a post-study surrey [J]. Eur J Clin Microbiol Infect Dis, 2010,29(3):269-277.
  • 6Casado Flores J,Blanco Quiros A.Procaleitionin,a new marker for bacte- rial infection [J].An Esp Pediatr,2001,54:69-73.
  • 7Christ M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibi- otic therapy in community-acquired pneumonia: a randomized trial [J] Am J Respir Crit Care Med,2006,174(1):14-93.
  • 8马明洲,张铮,秦海东,徐英,沈华.动态监测血清降钙素原在短程抗菌治疗策略中的临床价值[J].实用医学杂志,2010,26(7):1168-1170. 被引量:40
  • 9Assicot M,Gendrel D,CarsinH,et al.High serum procalcitonin concen- trations in patients with sepsis and infection [J].Lancet,1993,341(8844): 515-518.
  • 10Miedema KG,de Bont ES,Elferink RF,et al.The diagnostic value of CRP, IL-8,PCT,and TREM-1 in the detection of bacterial infections in pediatric oneology patients with febrile neutropenia [J].Suppert Care Cancer,2011,19(10):1593-1600.

二级参考文献12

  • 1何礼贤.值得研究和借鉴的短程抗菌治疗策略[J].中国抗感染化疗杂志,2005,5(5):318-319. 被引量:20
  • 2Levy M M, Fink M P, Marshall J C, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS international sepsis definitions conference [J]. Intensive Care Med, 2003,29 (4) : 530-538.
  • 3Wanner G A, Keel M, Steckholzer U, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients [J]. Crit Care Med,2000, 28(4) :950-957.
  • 4American Thoracic Society, Infectious Diseases Society. Guidelines for the management of adult with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia [J]. Am J Respir Crit Care Med, 2005,171 (4) : 388-416.
  • 5Assicot M, Gendrel D, Carsin H, et al. ,High serum procalcitonin concentrations in patients with sepsis and infection [J]. Lancet, 1993, 341 (8844) :515-518.
  • 6Al-Nakeeb S, Clermont G. Procalcitonin testing has the potential to reduce unnecessary antibiotic use in patients with suspected lower respiratory tract infections [ J ]. Crit Care, 2005,9 (3) : E5.
  • 7Bignardi G E, Dhar R, Heycock R, et al. Can procalcitonin testing reduce antibiotic prescribing for respiratory infections [J]? Age Ageing, 2006,35 (6) : 625-626.
  • 8Claeys R, V inken S, Spapen H, et al. Plasma proealcitonin and C- reactive protein in acute septic shock: clinical and biological correlates [J]. Cri/Care Mcd,2002,30(4) :757-762.
  • 9Dandona P, Nix D, Wilson M F, et al. Procalcitonin increase after endotoxin injection in normal subjects [J]. J Clin Endocrinol Metab, 1994,79(9) : 1605-1608.
  • 10Meisner M. Procaleitonin: a new, innovative infection parameter [ M ]. Berlin : Brahms Diagnostica, 1996 : 7-8.

共引文献39

同被引文献33

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部